Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group

Simple item page
dc.contributor.authorLihteh Wu
dc.contributor.authorJ. Fernando Arévalo
dc.contributor.authorErick Hernández-Bogantes
dc.contributor.authorJosé A. Roca
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:08:57Z
dc.date.available2026-03-22T14:08:57Z
dc.date.issued2012
dc.descriptionCitaciones: 42
dc.identifier.doi10.1007/s10792-012-9559-8
dc.identifier.urihttps://doi.org/10.1007/s10792-012-9559-8
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44826
dc.language.isoen
dc.publisherSpringer Science+Business Media
dc.relation.ispartofInternational Ophthalmology
dc.sourceInstituto de Microcirugía Ocular
dc.subjectMacular edema
dc.subjectMedicine
dc.subjectInfliximab
dc.subjectRefractory (planetary science)
dc.subjectOphthalmology
dc.subjectUveitis
dc.subjectVisual acuity
dc.subjectAdverse effect
dc.subjectRetrospective cohort study
dc.subjectTumor necrosis factor alpha
dc.titleIntravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group
dc.typearticle

Files

Collections

Artículo Científico Publicado